| MolName | (Z)-2-cyano-N-(oxolan-2-ylmethyl)-3-[1-phenyl-3-(3-piperidin-1-ylsulfonylphenyl)pyrazol-4-yl]prop-2-enamide |
| MolecularFormula | C29H31N5O4S |
| Smiles | N#C/C(/C(NCC1OCCC1)=O)=C/c1cn(-c2ccccc2)nc1-c1cccc(S(N2CCCCC2)(=O)=O)c1 |
| InChI | InChI=1S/C29H31N5O4S/c30-19-23(29(35)31-20-26-12-8-16-38-26)17-24-21-34(25-10-3-1-4-11-25)32-28(24)22-9-7-13-27(18-22)39(36,37)33-14-5-2-6-15-33/h1,3-4,7,9-11,13,17-18,21,26H,2,5-6,8,12,14-16,20H2,(H,31,35)/t26-/m1/s1 |
| InChIK | PAYISELTNFRUBZ-AREMUKBSSA-N |
| TotalMolweight | 545.662 |
| Molweight | 545.662 |
| MonoisotopicMass | 545.209675 |
| CLogP | 2.7052 |
| CLogS | -4.556 |
| H Acceptors | 9 |
| H Donors | 1 |
| TotalSurfaceArea | 414.59 |
| Relative PSA | 0.23645 |
| PolarSurfaceArea | 125.7 |
| Druglikeness | -3.4307 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.46154 |
| Fragments | 1 |
| Non HAtoms | 39 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 12 |
| Symmetricatoms | 5 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (Z)-2-cyano-N-(oxolan-2-ylmethyl)-3-[1-phenyl-3-(3-piperidin-1-ylsulfonylphenyl)pyrazol-4-yl]prop-2-enamide | 2 - (Z)-2-cyano-N-(oxolan-2-ylmethyl)-3-[1-phenyl-3-(3-piperidin-1-ylsulfonylphenyl)pyrazol-4-yl]prop-2-enamide